Gene · 3556
Papers2,323
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,323
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene expression and molecular pathway analyses differentiate immunotherapy-induced myositis from spontaneous dermatomyositis. | Sci Rep | 2025 | 40759686 | PubTator, text mining | PubMed |
| Characterization of novel anoikis-related genes as prognostic biomarkers and key determinants of the immune microenvironment in esophageal cancer. | Front Immunol | 2025 | 40746552 | PubTator, text mining | PubMed |
| Programmable protein ligation on cell surfaces. | Nature | 2025 | 40739351 | PubTator, text mining | PubMed |
| High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up. | Int J Cardiol | 2025 | 40716679 | PubTator, text mining | PubMed |
| Safety, efficacy, and analysis of biomarkers in patients with advanced non-small cell lung cancer treated with the anti-IL1RAP antibody nadunolimab (CAN04) in combination with platinum doublet. | Lung Cancer | 2025 | 40680438 | PubTator, text mining | PubMed |
| Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer. | Front Immunol | 2025 | 40666516 | PubTator, text mining | PubMed |
| Proinflammatory transcriptomic and kinomic alterations in astrocytes derived from patients with familial Alzheimer's disease. | Brain Behav Immun Health | 2025 | 40656638 | PubTator, text mining | PubMed |
| Machine learning-based construction of a programmed cell death-related model reveals prognosis and immune infiltration in pancreatic adenocarcinoma patients. | Sci Rep | 2025 | 40646168 | PubTator, text mining | PubMed |
| Antibody Matrimony in a Duel of Hearts. | JACC Basic Transl Sci | 2025 | 40562496 | PubTator, text mining | PubMed |
| Selenium deficiency is functionally linked with the molecular etiopathogenesis of necrotizing enterocolitis (NEC). | Funct Integr Genomics | 2025 | 40459789 | PubTator, text mining | PubMed |
| Galectin-9 induces IL-1β production as a key inflammatory cytokine in the acute myeloid leukemia cell line (U937). | Res Pharm Sci | 2025 | 40444162 | PubTator, text mining | PubMed |
| Integrated single-cell and transcriptome sequencing data reveal the value of IL1RAP in gastric cancer microenvironment and prognosis. | Front Oncol | 2025 | 40444099 | PubTator, text mining | PubMed |
| The role of IL-33 in immunotherapy for breast cancer: targets and signalling pathways. | Eur Cytokine Netw | 2025 | 40433883 | PubTator, text mining | PubMed |
| Updates in the Management of Hereditary Periodic Fever Syndromes in Children. | Cureus | 2025 | 40376361 | PubTator, text mining | PubMed |
| IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and Adhesion. | J Am Heart Assoc | 2025 | 40371594 | PubTator, text mining | PubMed |
| Comprehensive Clinical Analysis of Rilonacept in the Treatment of Cryopyrin-Associated Periodic Syndromes: A Systematic Review. | J Multidiscip Healthc | 2025 | 40370685 | PubTator, text mining | PubMed |
| Biological mechanisms and therapeutic prospects of interleukin-33 in pathogenesis and treatment of allergic disease. | J Inflamm (Lond) | 2025 | 40355878 | PubTator, text mining | PubMed |
| NAMPT-mediated deacetylation of HCLS1 protein promotes clonogenic growth of pediatric CML cells. | Exp Hematol | 2025 | 40349748 | PubTator, text mining | PubMed |
| Establishment and validation of a novel risk model based on PANoptosis-related genes to predict prognosis in head and neck squamous cell carcinoma. | Medicine (Baltimore) | 2025 | 40324259 | PubTator, text mining | PubMed |
| Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumors. | Invest New Drugs | 2025 | 40310569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3556/papers?page=4